Skip to main content
. 2018 Sep 12;132(21):2286–2297. doi: 10.1182/blood-2018-05-852277

Table 1.

Iron parameters of Tfr2BMKO/Hbbth3/+ mice 9 and 22 weeks after BMT

TS, % LIC, μg/g SIC, μg/g KIC, μg/g HIC, μg/g Hamp −ΔCt Hamp/LIC
9 wk after BMT Hbbth3/+ 49.9 ± 4.5 529.2 ± 23.7 4039 ± 69 248.0 ± 29.3 229.2 ± 10.8 5.79 ± 0.12 1.01 ± 0.09
Tfr2BMKO /Hbbth3/+ 41.1 ± 2.3 530.8 ± 72.4 3981 ± 172 249.8 ± 23.8 215.7 ± 15.1 5.90 ± 0.24 1.18 ± 0.14
22 wk after BMT Hbbth3/+ 31.1 ± 1.7 961.3 ± 98.2 7234 ± 779 401.3 ± 38.1 388.7 ± 19.4 5.03 ± 0.29 0.50 ± 0.05
Tfr2BMKO /Hbbth3/+ 30.3 ± 5.3 658.6 ± 83.0* 2383 ± 647*** 263.7 ± 21.4* 382.9 ± 29.7 2.80 ± 0.96* 0.31 ± 0.19

Mice were analyzed 9 and 22 weeks after transplantation with thalassemic (Hbbth3/+) or Tfr2−/−/Hbbth3/+ (Tfr2BMKO/Hbbth3/+) BM. Mice were fed a standard diet. The table reports: TS, LIC, SIC, KIC, HIC, and mRNA expression of hepcidin (Hamp) relative to Hprt1 and relative to LIC (Hamp/LIC). Mean values plus or minus SEs are indicated.

HIC, heart iron content; Hprt1, hypoxanthine phosphoribosyltransferase 1; KIC, kidney iron content; mRNA, messenger RNA.

Asterisks refer to statistically significant differences between age-matched Tfr2BMKO/Hbbth3/+ and Hbbth3/+ mice: *P < .05; ***P < .005.